Zurück zu Projekte

15523.1 PFLS-LS

Preparation of enantiopure antimalarial agent (+)-mefloquine

Zusammenfassung

Preparation of enantiopure antimalarial agent (+)-mefloquine

Weitere Texte

Abstract

Chiral amines are key components of pharmaceuticals but can be difficult, enviornmentally unfriendly, and|expensive to prepare. An excellent example of this problem is mefloquine, an anti-malerial drug currently|available only as a racemic mixture despite the fact that the (+)-enantiomer exhibits the desired activity while the side effects are associated with the (-)-enantiomer. This project will develop a new technology for separating the enantiomers of chiral amines from their mixtures on a kilogram scale. Working with Roche, this technology will be scaled up and used to prepare several hundred grams of enantiopure (+)-mefloquine, a quantity sufficient for early stage clinical trials.

Beteiligte

Alec Fettes

Wirtschaftspartner

alec.fettes@roche.com

F. Hoffmann-La Roche Ltd CHE-105.815.381 Alec Fettes Building 65/618 / Grenzacherstrasse 124 4070 Basel BS CH

Jeffrey Bode

Kontaktperson

bode@org.chem.ethz.ch

ETH Zürich Jeffrey Bode Wolfgang-Pauli-Strasse 10 8093 Zürich ZH CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2013-11-30
Enddatum
2015-11-30
Bewilligte Gesamtkosten
CHF 294310.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T490 Biotechnology 100.0%